Vanda Pharmaceuticals
VNDA
#8337
Rank
NZ$0.52 B
Marketcap
NZ$8.68
Share price
-1.54%
Change (1 day)
22.57%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -NZ$0.28 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.21 Billion. In 2025 the company made an earning of -NZ$0.26 Billion a decrease over its 2024 earnings that were of -NZ$69.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.28 Billion6.57%
2025 -NZ$0.26 Billion271.79%
2024 -NZ$69.19 Million191.43%
2023 -NZ$23.74 Million-320.45%
2022 NZ$10.76 M-84.99%
2021 NZ$71.74 M54.8%
2020 NZ$46.34 M19.42%
2019 NZ$38.81 M4.93%
2018 NZ$36.98 M-228.6%
2017 -NZ$28.77 Million-8.98%
2016 -NZ$31.6 Million-53.79%
2015 -NZ$68.38 Million-30.18%
2014 -NZ$97.93 Million173.08%
2013 -NZ$35.87 Million-25.33%
2012 -NZ$48.03 Million163.61%
2011 -NZ$18.22 Million-221.15%
2010 NZ$15.03 M-124.53%
2009 -NZ$61.31 Million-29.44%
2008 -NZ$86.89 Million-36.2%
2007 -NZ$0.14 Billion21.81%
2006 -NZ$0.12 Billion170.55%
2005 -NZ$41.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.20 B-16,300.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$26.85 B-9,942.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.02 B-6,704.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$52.95 B-19,508.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.37 B-8,301.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.32 B-6,084.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-NZ$4.78 Million-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA